The Role of Research in Viral Disease Eradication and Elimination Programs: Lessons for Malaria Eradication

English version České info

By examining the role research has played in eradication or regional elimination initiatives for three viral diseases—smallpox, poliomyelitis, and measles—we derive nine cross-cutting lessons applicable to malaria eradication. In these initiatives, some types of research commenced as the programs began and proceeded in parallel. Basic laboratory, clinical, and field research all contributed notably to progress made in the viral programs. For each program, vaccine was the lynchpin intervention, but as the programs progressed, research was required to improve vaccine formulations, delivery methods, and immunization schedules. Surveillance was fundamental to all three programs, whilst polio eradication also required improved diagnostic methods to identify asymptomatic infections. Molecular characterization of pathogen isolates strengthened surveillance and allowed insights into the geographic source of infections and their spread. Anthropologic, sociologic, and behavioural research were needed to address cultural and religious beliefs to expand community acceptance. The last phases of elimination and eradication became increasingly difficult, as a nil incidence was approached. Any eradication initiative for malaria must incorporate flexible research agendas that can adapt to changing epidemiologic contingencies and allow planning for posteradication scenarios.

Vyšlo v časopise: The Role of Research in Viral Disease Eradication and Elimination Programs: Lessons for Malaria Eradication. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000405
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000405

Souhrn

Zdroje

1. HinmanA

1999 Eradication of vaccine-preventable diseases. Annu Rev Public Health 20 211 229

2. FennerF

HendersonDA

AritaI

JezekZ

LadnyiID

1988 Smallpox and its eradication. Geneva World Health Organization

3. AritaI

1972 The control of vaccine quality in the smallpox eradication programme. International Symposium on Smallpox Vaccine. 19. Basel Karger. Symposium Series on Immunobiological Standardization

4. SparkesJD

FenjeP

1972 The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures. Bull World Health Organ 46 729 734

5. RobertoRR

WulffH

MillarJD

1969 Smallpox vaccination by intradermal jet injection. 2. Cutaneous and serological responses to primary vaccination in children. Bull World Health Organ 41 761 769

6. PattanayakS

AroraDD

SehgalCL

RaghavanNG

TopaPK

1970 Comparative studies of smallpox vaccination by the bifurcated needle and rotary lancet techniques. Bull World Health Organ 42 305 310

7. ThomasDB

AritaI

McCormackWM

KhanMM

IslamS

1971 Endemic smallpox in rural East Pakistan. II. Intervillage transmission and infectiousness. Am J Epidemiol 93 373 383

8. FoegeWH

MillarJD

LaneJM

1971 Selective epidemiologic control in smallpox eradication. Am J Epidemiol 94 311 315

9. MackTM

ThomasDB

MuzaffarKM

1972 Epidemiology of smallpox in West Pakistan. II. Determinants of intravillage spread other than acquired immunity. Am J Epidemiol 95 169 177

10. BasuRN

JezekZ

WardNA

1979 The eradication of smallpox from India. 2. History of International Public Health New Delhi World Health Organization, Southeast Asia Regional Office

11. FoegeWH

MillarJD

HendersonDA

1975 Smallpox eradication in West and Central Africa. Bull World Health Organ 52 209 222

12. HughesK

FosterSO

TarantolaD

MehtaH

TullochJL

1980 Smallpox surveillance in Bangladesh: II - Smallpox facial scar survey assessment of surveillance effectiveness. Int J Epidemiol 9 335 340

13. RubenFL

SmithEA

FosterSO

CaseyHL

PiferJM

1973 Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ 48 175 181

14. AylwardRB

CochiSL

HeymannDL

2009 Polio eradication: ongoing innovation to end an ancient scourge.

LevineMM

DouganG

GoodMF

LiuMA

NabelGJ

New generation vaccines New York Informa Healthcare 4th edition

15. BaptistaRJJr

1984 The control of poliomyelitis in Brazil. Rev Infect Dis 6 Suppl 2 S400 S403

16. DowdleW

CochiS

2002 Global eradication of poliovirus: history and rationale.

SemlerB

WimmerE

Molecular biology of picornaviruses Washington (D.C.) American Society for Microbiology

17. De QuadrosCA

HershBS

OliveJM

AndrusJK

Da SilveiraCM

1997 Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 175 Suppl 1 S37 S42

18. World Health Organization Expanded Programme on Immunization 1997 Expanded programme on immunization (EPI). Progress towards the global eradication of poliomyelitis, 1996. Wkly Epidemiol Rec 72 189 194

19. KewO

Morris-GlasgowV

LandaverdeM

BurnsC

ShawJ

2002 Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296 356 359

20. KewOM

SutterRW

de GourvilleEM

DowdleWR

PallanschMA

2005 Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 587 635

21. Ad Hoc Advisory Committee on Poliomyelitis Eradication 2004 Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004. Wkly Epidemiol Rec 79 401 407

22. Polio Research Committee 2010 Polio Research Committee: conclusions and recommendations. The polio pipeline Geneva Global Polio Eradication Initiative, World Health Organization

23. Advisory Committee on Poliomyelitis Eradication 2009 Advisory Committee on Poliomyelitis Eradication: recommendations on the use of bivalent oral poliovirus vaccine types 1 and 3. Wkly Epidemiol Rec 84 289 290

24. ObregonR

ChitnisK

MorryC

FeekW

BatesJ

2009 Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ 87 624 630

25. TebbensRJ

PallanschMA

KewOM

CaceresVM

JafariH

2006 Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal 26 1471 1505

26. DukeT

MgoneCS

2003 Measles: not just another viral exanthem. Lancet 361 763 773

27. BlackFL

1966 Measles endemicity in insular populations: critical community size and its evolutionary implication. J Theor Biol 11 207 211

28. GindlerJ

TinkerS

MarkowitzL

AtkinsonW

DalesL

2004 Acute measles mortality in the United States, 1987-2002. J Infect Dis 189 Suppl 1 S69 S77

29. De QuadrosCA

2004 Can measles be eradicated globally? Bull World Health Organ 82 134 138

30. World Health Organization 2007 Progress in global measles control and mortality reduction, 2000-2006. Wkly Epidemiol Rec 82 418 424

31. TakpaV

MorgahK

GbedonouP

EliadesM

2005 Distribution of insecticide-treated bednets during an integrated nationwide immunization campaign–Togo, West Africa, December 2004. MMWR Morb Mortal Wkly Rep 54 994 996

32. GraisRF

DubrayC

GerstlS

GuthmannJP

DjiboA

2007 Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med 4 e16 doi:10.1371/journal.pmed.0040016

33. TischerA

SantibanezS

SiedlerA

HeiderA

HengelH

2004 Laboratory investigations are indispensable to monitor the progress of measles elimination–results of the German Measles Sentinel 1999-2003. J Clin Virol 31 165 178

34. MuldersMN

TruongAT

MullerCP

2001 Monitoring of measles elimination using molecular epidemiology. Vaccine 19 2245 2249

35. OmerSB

HiremathGS

HalseyNA

2010 Respiratory administration of measles vaccine. Lancet 375 706 708

36. PasettiMF

Resendiz-AlborA

RamirezK

StoutR

PapaniaM

2007 Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques. Clin Pharmacol Ther 82 672 685

37. RimoinAW

MulembakaniPM

JohnstonSC

Lloyd SmithJO

KisaluNK

2010 Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A 107 16262 16267

38. LadnyjID

ZieglerP

KimaE

1972 A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 46 593 597

39. JezekZ

FennerF

1988 Human monkeypox. Monographs in Virology Basel Karger

40. BremanJG

2000 Monkeypox: an emerging infection for humans?

ScheldWM

CraigWA

HughesJM

Emerging infections Washington (D.C.) ASM Press

41. DaneshvarC

DavisTM

Cox-SinghJ

Rafa'eeMZ

ZakariaSK

2009 Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis 49 852 860

42. NathansonN

MartinJR

1979 The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol 110 672 692

43. NathansonN

KewOM

2010 From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 172 1213 1229

44. BelliniWJ

HelfandRF

2003 The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 187 Suppl 1 S283 S290

45. RamsayME

JinL

WhiteJ

LittonP

CohenB

2003 The elimination of indigenous measles transmission in England and Wales. J Infect Dis 187 Suppl 1 S198 S207

46. DumbellKR

ArchardLC

1980 Comparison of white pock (h) mutants of monkeypox virus with parental monkeypox and with variola-like viruses isolated from animals. Nature 286 29 32

47. NakanoJH

1980 Smallpox, monkeypox, vaccinia, and whitepox viruses.

LennetteEH

TruantJP

Manual of clinical microbiology Washington (D.C.) American Society for Microbiology 3rd edition

48. KewOM

MuldersMN

LipskayaGY

da SilvaEE

PatlanschMA

1995 Molecular epidemiology of polioviruses.

NathansonN

Seminars in virology New York Academic Press

49. RubinBA

1980 A note on the development of the bifurcated needle for smallpox vaccination. WHO Chron 34 180 181

50. HendersonRH

DavisH

EddinsDL

FoegeWH

1973 Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa. Bull World Health Organ 48 183 194

51. ContehS

ChattopadhyayR

AndersonC

HoffmanSL

2010 Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route. PLoS ONE 5 e8947 doi:10.1371/journal.pone.0008947

52. Van BuskirkKM

O'NeillMT

De La VegaP

V, MaierAG

KrzychU

2009 Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 106 13004 13009

53. HoffmanSL

BillingsleyPF

JamesE

RichmanA

LoyevskyM

2010 Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6 97 106

54. CrottyS

FelgnerP

DaviesH

GlidewellJ

VillarrealL

2003 Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 4969 4973

55. PatriarcaPA

WrightPF

JohnTJ

1991 Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev of Inf Dis 13 926 929

56. VashishthaVM

KalraA

JohnTJ

ThackerN

AgarwalRK

2008 Recommendations of 2nd National Consultative Meeting of Indian Academy of Pediatrics (IAP) on polio eradication and improvement of routine immunization. Indian Pediatr 45 367 378

57. JohnTJ

JayabalP

1972 Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 96 263 269

58. JohnTJ

1972 Problems with oral poliovaccine in India. Indian Pediatr 9 252 256

59. SutterR

JohnTJ

JainH

AgarkhedkarS

RamananP

2010 Randomized clinical trial of bivalent type 1 and 3 oral poliovirus vaccine. Lancet 376 1682 1688

60. FoegeWH

LelandOS

MollahanCS

FulginitiVA

HendersonDA

1965 Inactivated measles-virus vaccine. Public Health Rep 80 60 64

61. FulginitiVA

EllerJJ

DownieAW

KempeCH

1967 Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202 1075 1080

62. RauhLW

SchmidtR

1965 Measles immunization with killed virus vaccine. Serum antibody titers and experience with exposure to measles epidemic. Am J Dis Child 109 232 237

63. SencerDJ

DullHB

LangmuirAD

1967 Epidemiologic basis for eradication of measles in 1967. Public Health Rep 82 253 256

64. StrebelPM

Henao-RestrepoAM

HoekstraE

OliveJM

PapaniaMJ

2004 Global measles elimination efforts: the significance of measles elimination in the United States. J Infect Dis 189 Suppl 1 S251 S257

65. TapiaM

SowS

Medina-MorenoSM

LimY

PasettiMF

2005 A serosurvey to identify the “window of vulnerability” to wild type measles among infants in rural Mali. Am J Trop Med Hyg 73 26 31

66. WhittleH

HanlonP

O'NeillK

HanlonL

MarshV

1988 Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet 2 811 814

67. World Health Organization 1992 Expanded programme on immunization (EPI). Safety of high titre measles vaccines. Wkly Epidemiol Rec 67 357 361

68. TaylorWR

MambuRK

ma-DisuM

WeinmanJM

1988 Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 127 788 794

69. SimonJK

PasettiMF

ViretJF

MischlerR

MunozA

2007 A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults. Hum Vaccin 3 54 58

70. KhetsurianiN

PrevotsDR

QuickL

ElderME

PallanschM

2003 Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis 188 1845 1852

71. AgurZ

CojocaruL

MazorG

AndersonRM

DanonYL

1993 Pulse mass measles vaccination across age cohorts. Proc Natl Acad Sci U S A 90 11698 11702

72. BauchCT

SzuszE

GarrisonLP

2009 Scheduling of measles vaccination in low-income countries: projections of a dynamic model. Vaccine 27 4090 4098

73. SzuszEK

GarrisonLP

BauchCT

2010 A review of data needed to parameterize a dynamic model of measles in developing countries. BMC Res Notes 3 75

74. PongtavornpinyoW

HastingsIM

DondorpA

WhiteLJ

MaudeRJ

2009 Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Evol Appl 2 52 61

75. JegedeAS

2007 What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med 4 e73 doi:10.1371/journal.pmed.0040073

76. Centers for Disease Control and Prevention 2010 Progress toward poliomyelitis eradication - Nigeria, January 2009-June 2010. MMWR Morb Mortal Wkly Rep 59 802 807

77. WaisbordS

ShimpL

OgdenEW

MorryC

2010 Communication for polio eradication: improving the quality of communication programming through real-time monitoring and evaluation. J Health Commun 15 Suppl 1 9 24

78. BruceAR

SutterRW

CochiSL

ThompsonKM

JafariH

2006 Risk management in a polio-free world. Risk Anal 26 1441 1448